RE-IRRADIATION WITH AND WITHOUT BEVACIZUMAB IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMAS (HGG): RETROSPECTIVE ANALYSIS OF 13 PATIENTS

被引:0
|
作者
Hundsberger, T. [1 ,2 ]
Bruegge, D. [3 ]
Weder, P. [2 ]
Weber, J. [4 ]
Plasswilm, L. [3 ]
机构
[1] Dept Neurol, St Gallen, Switzerland
[2] Div Haematol Oncol, St Gallen, Switzerland
[3] Dept Radiooncol, St Gallen, Switzerland
[4] Inst Radiol, St Gallen, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:88 / 88
页数:1
相关论文
共 50 条
  • [31] OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG) TREATED WITH BEVACIZUMAB
    Ye, L.
    Hasani, A.
    Nowak, A.
    King, A.
    Long, A.
    Trevenen, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 72 - 72
  • [32] A RETROSPECTIVE ANALYSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS TREATED WITH BEVACIZUMAB WITH OR WITHOUT IRINOTECAN: THE MOFFITT CANCER CENTER EXPERIENCE
    Potthast, Lisa
    Chowdhary, Sajeel
    Pan, Edward
    Yu, Daohai
    Brem, Steven
    NEURO-ONCOLOGY, 2008, 10 (05) : 831 - 831
  • [33] Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomas
    Mahase, Sean S.
    Roytman, Michelle
    O'Brien, Diana Roth
    Ivanidze, Jana
    Schwartz, Theodore H.
    Pannullo, Susan C.
    Ramakrishna, Rohan
    Magge, Rajiv S.
    Williams, Nicholas
    Fine, Howard A.
    Chiang, Gloria Chia-Yi
    Knisely, Jonathan P. S.
    CANCER REPORTS, 2023, 6 (07)
  • [34] Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment
    Wenyin Shi
    Erik S. Blomain
    Joshua Siglin
    Joshua D. Palmer
    Tu Dan
    Yang Wang
    Maria Werner-Wasik
    Jon Glass
    Lyndon Kim
    Voichita Bar Ad
    Deepak Bhamidipati
    James J. Evans
    Kevin Judy
    Christopher J. Farrell
    David W. Andrews
    Journal of Neuro-Oncology, 2018, 137 : 171 - 177
  • [35] RE-IRRADIATION FOR CHILDREN WITH RECURRENT SUPRATENTORIAL HIGH-GRADE GLIOMA
    Oliveira, Carol
    Laperriere, Normand J.
    Bouffet, Eric
    Hawkins, Cynthia
    Ramaswamy, Vijay
    Yee, Ryan
    Tabori, Uri
    Bartels, Ute
    Huang, Annie
    Millar, Barbara-Ann
    Crooks, Bruce
    Bowes, Lynette
    Zelcer, Shayna
    Tsang, Derek S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S45 - S45
  • [36] PATTERNS OF RECURRENCE IN PATIENTS TREATED WITH RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA
    Datta, Debanjali
    Dasgupta, Archya
    Meena, Lilawati
    Chatterjee, Abhishek
    Sahu, Arpita
    Chaudhari, Amit
    Joshi, Kishore
    Puranik, Ameya
    Rangarajan, Venkatesh
    Singh, Vikas
    Shetty, Prakash
    Moiyadi, Aliasgar
    Menon, Nandini
    Patil, Vijay
    Sahay, Ayushi
    Sridhar, Epari
    Kinhikar, Rajesh
    Gupta, Tejpal
    NEURO-ONCOLOGY, 2022, 24 : 55 - 55
  • [37] Temozolomide Rechallenge in Patients With Recurrent High-Grade Glioma Treated With Re-Irradiation
    Basree, M. M.
    Ali, A.
    Garg, S.
    Glass, J.
    Kim, L.
    Farrell, C.
    Evans, J.
    Judy, K.
    Andrews, D. W.
    Shi, W.
    Werner-Wasik, M.
    Palmer, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E587 - E588
  • [38] Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
    Prakirthi Yerram
    Samantha N. Reiss
    Lisa Modelevsky
    Igor T. Gavrilovic
    Thomas Kaley
    Journal of Neuro-Oncology, 2019, 145 : 57 - 63
  • [39] Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
    Yerram, Prakirthi
    Reiss, Samantha N.
    Modelevsky, Lisa
    Gavrilovic, Igor T.
    Kaley, Thomas
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) : 57 - 63
  • [40] lRE-IRRADIATION PLUS BEVACIZUMAB TREATMENT IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS
    Dinh, Jeffrey
    Grosshans, David
    Allen, Pamela
    De Groot, John
    McGovern, Susan
    McAleer, Mary
    Gilbert, Mark
    Brown, Paul
    Mahajan, Anita
    NEURO-ONCOLOGY, 2013, 15 : 181 - 181